Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
HCW Biologics Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Winer Gary M (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.01, valued at
$25.1k
|
|
| 06/15/2023 |
4
| GARRETT SCOTT T (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.01, valued at
$25.1k
|
|
| 06/15/2023 |
4
| Greene Rick S. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.01, valued at
$25.1k
|
|
| 06/15/2023 |
4
| Giles Lisa M. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.01, valued at
$25.1k
|
|
| 06/09/2023 |
4
| Flowers Lee (SVP of Business Development) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 10,000 shares
@ $2.1574, valued at
$21.6k
Exercised 5,356 options to buy
@ $0.14, valued at
$749.8 |
|
| 06/09/2023 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 20,000 shares
@ $2.0643, valued at
$41.3k
|
|
| 06/08/2023 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 20,000 shares
@ $2.0316, valued at
$40.6k
Bought 4,696 shares
@ $2.212, valued at
$10.4k
|
|
| 06/07/2023 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 20,000 shares
@ $1.6672, valued at
$33.3k
Bought 19,062 shares
@ $1.8245, valued at
$34.8k
|
|
| 06/02/2023 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 800 shares
@ $1.6178, valued at
$1.3k
Bought 800 shares
@ $1.5353, valued at
$1.2k
|
|
| 06/01/2023 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 3,000 shares
@ $1.5527, valued at
$4.7k
Bought 2,000 shares
@ $1.546, valued at
$3.1k
|
|
| 06/01/2023 |
4
| Winer Gary M (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 850 shares
@ $1.5206, valued at
$1.3k
Bought 500 shares
@ $1.5, valued at
$750 |
|
| 05/31/2023 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 20,000 shares
@ $1.6174, valued at
$32.3k
Bought 20,000 shares
@ $1.6598, valued at
$33.2k
|
|
| 05/24/2023 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 33,450 shares
@ $1.526, valued at
$51k
Bought 5,036 shares
@ $1.5662, valued at
$7.9k
Bought 20,000 shares
@ $1.6075, valued at
$32.2k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 15,000 shares
@ $2.5767, valued at
$38.7k
|
|
| 09/14/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 15,000 shares
@ $2.6509, valued at
$39.8k
Bought 15,000 shares
@ $2.5767, valued at
$38.7k
|
|
| 09/12/2022 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 4,000 shares
@ $2.67, valued at
$10.7k
Bought 6,000 shares
@ $2.7, valued at
$16.2k
|
|
| 09/07/2022 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 4,000 shares
@ $2.55, valued at
$10.2k
Bought 6,000 shares
@ $2.58, valued at
$15.5k
|
|
| 09/01/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 7,200 shares
@ $2.5474, valued at
$18.3k
Bought 10,000 shares
@ $2.5572, valued at
$25.6k
|
|
| 08/30/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 10,000 shares
@ $2.5358, valued at
$25.4k
Bought 10,000 shares
@ $2.5662, valued at
$25.7k
|
|
| 08/26/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 50,000 shares
@ $2.5045, valued at
$125.2k
Bought 40,300 shares
@ $2.5936, valued at
$104.5k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Greene Rick S. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 41,841 options to buy
@ $2.39, valued at
$100k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Byam Rebecca (CFO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 7,596 shares
@ $2.0817, valued at
$15.8k
Bought 58,856 shares
@ $2.4634, valued at
$145k
|
|
| 06/13/2022 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 1,520 shares
@ $2.188, valued at
$3.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Wong Hing C (CEO) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 1,000 shares
@ $2.31, valued at
$2.3k
Bought 2,000 shares
@ $2.245, valued at
$4.5k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Greene Rick S. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 4,800 shares
@ $2.0918, valued at
$10k
|
|
| 06/02/2022 |
4
| Jiao Jin-an (VP of Development) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Exercised 12,856 options to buy
@ $0.14, valued at
$1.8k
Exercised 1,714 options to buy
@ $0.21, valued at
$359.9 |
|
| 01/19/2022 |
4
| Rhode Peter (See Remarks) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Exercised 1,714 options to buy
@ $0.21, valued at
$359.9
Exercised 1 options to buy
@ $0.14, valued at
$0.1 |
|
| 12/07/2021 |
4
| Jiao Jin-an (VP of Development) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Bought 10,000 shares
@ $2.415, valued at
$24.2k
|
|
|
|
|